Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter

Explore clinical trials studying Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter trial results

Completed

Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function

NCT00478361

Conditions: Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
Locations: Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield Springfield, Missouri, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

NCT01846520

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract

NCT00112671

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +15 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

NCT00407485

Conditions: Adenocarcinoma of the Bladder, Distal Urethral Cancer, Female Urogenital Diseases, +23 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma

NCT00072150

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +22 more
Locations: UCSF-Mount Zion San Francisco, California, United States

View Trial Details

Completed

Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

NCT00041106

Conditions: Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

NCT00021099

Conditions: Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer

NCT00005831

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter trial results

Related conditions